Synopsis of recent research by authors named "Tanya Dorff"
Tanya Dorff's research focuses extensively on various therapeutic approaches and biomarkers in prostate cancer, particularly in context of metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC) patients.
Recent studies highlight the potential of novel treatments, including white button mushroom therapy and circulating tumor cell (CTC) counts, to improve patient outcomes and prognostication in prostate cancer management.
Dorff's work also addresses public health considerations, such as tobacco use among cancer trial participants and barriers to clinical trial enrollment, emphasizing the need for improved strategies to enhance patient participation in clinical research.
